ArticleReproduction & fertility2026
Transcriptome differences in lesions by color, and cancer mutations in endometriosis.
Article in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractEndometriosis is a disease where cells similar to those of the uterine lining grow outside of the uterus, embedding into tissues and organs in the abdominal cavity, forming lesions and causing pain and infertility. Previous studies in patients with endometriosis identified single nucleotide polymorphisms associated with the disease, as well as somatic mutations in cancer-related genes. Here, we use bulk RNA sequencing to determine transcriptome mutation profiling and differentially expressed genes in endometriotic lesions, peritoneum, and eutopic endometrium of patients with endometriosis and control patients. Differential gene expression analysis revealed differences in the transcriptome in lesions based on their color, specifically increased inflammatory processes in red lesions compared with clear lesions. Furthermore, lesions expressed an increase in cell proliferation and estrogen response genes compared with eutopic endometrium. We identified an increased occurrence of somatic mutations in cancer-associated genes ARID1A, KRAS, PIK3CA, ARHGAP35, and PBRM1, which were conserved between lesions, peritoneum, and eutopic endometrium, in patients with endometriosis without cancer. These mutations arising from eutopic endometrium may have a role in the establishment and progression of the disease. Importantly, our findings suggest that excision of the visible endometriotic lesion tissue during surgery may not be sufficient for the complete removal of the lesion, leading to recurrence. LAY SUMMARY: Endometriosis is a condition in which tissue similar to the lining of the uterus (endometrium) grows on pelvic organs, causing pain and affecting fertility. We used RNA sequencing to measure differences in gene expression across three types of tissues: lesions, endometrium, and peritoneum (the membrane that covers internal organs where endometriosis lesions grow). We found that red lesions expressed more inflammation-related genes than clear lesions and that endometriosis lesions had more signs of cell growth and estrogen response than the other tissues. We also found mutations in genes linked to cancer across the three tissues in patients without cancer. These findings suggest that endometriosis may start or spread from changes in the uterine lining and that removing only the visible lesions during surgery may not always remove all of the disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.